
		From Wikipedia, the free encyclopedia
		
		
		
		
		Jump to navigation
		Jump to search
		Vaccine adjuvant
Matrix-M adjuvant is a saponin-based adjuvant, patented by Novavax, that stimulates humoral and cellular immune responses to vaccines.[1][2][3] It is composed of nanoparticles from saponins extracted from Quillaja saponaria (soapbark) trees, cholesterol, and phospholipids.[4][5][6] It is an immune stimulating complex (ISCOM), which are nanospheres formed when saponin is mixed with two types of fats.[7]
Adjuvants increase the body's immune response to a vaccine by creating higher levels of antibodies.[8] They can either enhance, modulate, and/or prolong the body's immune response, reducing the number of vaccinations needed for immunization.[9]
The Matrix-M adjuvant is used in a number of vaccine candidates, including the malaria vaccine R21/Matrix-M,[1][10] influenza vaccines,[2] and the Novavax COVID-19 vaccine.[4][11] In 2021, the R21/Matrix-M vaccine candidate showed a 77% efficacy over a 12-month period.[10][4] In influenza vaccine candidates, Matrix-M was shown to offer cross-protection against multiple strains of influenza.[11][2][3]
Novavax is also testing a combined flu and COVID-19 vaccine candidate with Matrix-M.[12]

References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Jump up to: a b .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Datoo, Mehreen S.; Natama, Magloire H.; Somé, Athanase; Traoré, Ousmane; Rouamba, Toussaint; Bellamy, Duncan; Yameogo, Prisca; Valia, Daniel; Tegneri, Moubarak; Ouedraogo, Florence; Soma, Rachidatou (2021-05-15). "Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial". The Lancet. 397 (10287): 1809–1818. doi:10.1016/S0140-6736(21)00943-0. ISSN 0140-6736. PMC 8121760. PMID 33964223.

^ Jump up to: a b c Magnusson, Sofia E.; Reimer, Jenny M.; Karlsson, Karin H.; Lilja, Lena; Bengtsson, Karin Lövgren; Stertman, Linda (2013-03-25). "Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice". Vaccine. 31 (13): 1725–1733. doi:10.1016/j.vaccine.2013.01.039. ISSN 0264-410X.

^ Jump up to: a b "NanoFlu is on the FDA's Vaccine Fast-Track". www.precisionvaccinations.com. Retrieved 2021-10-27.

^ Jump up to: a b c Satyanarayana, Megha (2021-08-17). "A new, powerful malaria vaccine may be on the horizon". cen.acs.org. Retrieved 2021-10-27.{{cite web}}:  CS1 maint: url-status (link)

^ "Is Old Vaccine Technology the Key to Hesitancy?". www.medpagetoday.com. 2021-06-17. Retrieved 2021-10-28.

^ King2021-02-04T14:10:00+00:00, Anthony. "Covid vaccination efforts bolstered by trial results from J&J and Novavax". Chemistry World. Retrieved 2021-10-28.

^ Milicic, Anita. "Adjuvants: the unsung heroes of vaccines". The Conversation. Retrieved 2021-10-28.

^ "Moths and tree bark: How the Novavax vaccine works". www.nebraskamed.com. Retrieved 2021-10-27.

^ Bonam, Srinivasa Reddy; Partidos, Charalambos D.; Halmuthur, Sampath Kumar M.; Muller, Sylviane (September 2017). "An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy". Trends in Pharmacological Sciences. 38 (9): 771–793. doi:10.1016/j.tips.2017.06.002. ISSN 1873-3735. PMID 28668223.

^ Jump up to: a b "Malaria vaccine becomes first to achieve WHO-specified 75 percent efficacy goal". ScienceDaily. Retrieved 2021-10-27.

^ Jump up to: a b Borrell, Brendan (2020-10-21). "The Tree That Could Help Stop the Pandemic". The Atlantic. Retrieved 2021-10-26.

^ News, Sarah Jane Tribble, Rachana Pradhan, Kaiser Health. "Novavax's effort to vaccinate the world, from zero to not quite warp speed". Quartz. Retrieved 2021-10-28.




.mw-parser-output .asbox{position:relative;overflow:hidden}.mw-parser-output .asbox table{background:transparent}.mw-parser-output .asbox p{margin:0}.mw-parser-output .asbox p+p{margin-top:0.25em}.mw-parser-output .asbox-body{font-style:italic}.mw-parser-output .asbox-note{font-size:smaller}.mw-parser-output .asbox .navbar{position:absolute;top:-0.75em;right:1em;display:none}This biology article is a stub. You can help Wikipedia by expanding it..mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vte
This article about Medicinal chemistry is a stub. You can help Wikipedia by expanding it.vte




<img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" />
Retrieved from "https://en.wikipedia.org/w/index.php?title=Matrix-M&oldid=1064896282"
		Categories: AdjuvantsSaponinsImmunostimulantsTriterpene glycosidesBiology stubsMedicinal chemistry stubsHidden categories: CS1 maint: url-statusArticles with short descriptionShort description matches WikidataAll stub articles
	